Role of IL-1 Beta in the Development of Human TH17 Cells: Lesson from NLPR3 Mutated Patients
Open Access
- 26 May 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (5), e20014
- https://doi.org/10.1371/journal.pone.0020014
Abstract
T helper 17 cells (TH-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1β has been indicated as a key cytokine for the commitment to TH-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1β secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of TH17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1β, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1β blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of TH17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of TH17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and TH17 frequency were observed in CAPS patients following in vivo IL-1β blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. These findings further support the central role of IL-1β in the differentiation of TH17 in human inflammatory conditions.Keywords
This publication has 56 references indexed in Scilit:
- Generation of pathogenic TH17 cells in the absence of TGF-β signallingNature, 2010
- Interleukin‐9 as a T helper type 17 cytokineImmunology, 2010
- Follow-Up and Quality of Life of Patients with Cryopyrin-Associated Periodic Syndromes Treated with AnakinraThe Journal of Pediatrics, 2010
- Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environmentProceedings of the National Academy of Sciences, 2010
- Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)Molecular Cancer Therapeutics, 2010
- Dectin-2 Recognition of α-Mannans and Induction of Th17 Cell Differentiation Is Essential for Host Defense against Candida albicansImmunity, 2010
- Development, regulation and functional capacities of Th17 cellsSeminars in Immunopathology, 2010
- Interleukin-17 and Type 17 Helper T CellsNew England Journal of Medicine, 2009
- Development, cytokine profile and function of human interleukin 17–producing helper T cellsNature Immunology, 2007
- Phenotypic and functional features of human Th17 cellsThe Journal of Experimental Medicine, 2007